Skip to main content
Chemotherapy Research and Practice logoLink to Chemotherapy Research and Practice
. 2011 Mar 3;2011:218750. doi: 10.1155/2011/218750

Antibacterial and Antioxidant Properties of the Methanolic Extract of the Stem Bark of Pteleopsis hylodendron (Combretaceae)

Aristide Laurel Mokale Kognou 1, Rosalie Annie Ngono Ngane 2,*, Jules Roger Kuiate 1, Martin Luther Koanga Mogtomo 2, Alembert Tchinda Tiabou 3, Raymond Simplice Mouokeu 1, Lucie Biyiti 4, Paul Henri Amvam Zollo 4
PMCID: PMC3265253  PMID: 22312549

Abstract

Pteleopsis hylodendron (Combretaceae) is used in Cameroon and West Africa folk medicine for the treatment of various microbial infections (measles, chickenpox, and sexually transmitted diseases). The antibacterial properties of the methanolic extract and fractions from stem bark of Pteleopsis hylodendron were tested against three Gram-positive bacteria and eight Gram-negative bacteria using Agar-well diffusion and Broth microdilution methods. Antioxidant activities of the crude extract and fractions were investigated by DPPH radical scavenging activity and β-carotene-linoleic acid assays. The methanolic extract and some fractions exhibited antibacterial activities that varied between the bacterial species (ID = 0.00–25.00 mm; MIC = 781–12500 μg/mL and 0.24–1000 μg/mL). The activity of the crude extract is, however, very weak compared to the reference antibiotics (MIC = 0.125–128 μg/mL). Two fractions (FE and FF) showed significant activity (MIC = 0.97 μg/mL) while S. aureus ATCC 25922 was almost resistant to all the tested fractions. In addition, the crude extract and some fractions showed good antioxidant potential with inhibition values ranging from 17.53 to 98.79%. These results provide promising baseline information for the potential use of this plant as well as some of the fractions in the treatment of infectious diseases and oxidative stress.

1. Introduction

Since the successive introduction of various antibiotics into therapeutics, the sensitivity of pathogenic microorganisms changed a lot so that the proportion of antibiotically resistant strains is currently important [1], what involves an increase in seriousness of infectious diseases as gastroenteritis (GE) which are a problem of public health on a worldwide scale but especially in Africa [2]. Diarrhea, its main characteristic is a major cause of morbidity and mortality among children in developing countries. According to the World Health Organization (WHO), there are more than 2 million deaths per year [3]. Moreover, therapy with synthetic antibiotics is not always possible because of their high cost as well as toxicity due to their extended use. To overcome this problem, people in developing countries use preparations obtained from plants following folk tradition for their primary health care because of low cost with little or no undesirable side effects [4]. The plants represent a potential and almost inexhaustible source of new anti-infective compounds [5] and many of them are used to treat GE effectively [6].

Pteleopsis hylodendron Mildbr. belongs to the family Combretaceae commonly found in the forest regions of West and Central Africa. The genus Pteleopsis is represented in Africa by ten species but only P. hylodendron is found in Cameroon [7]. The aqueous decoction of the stem bark of P. hylodendron is used to treat measles, chickenpox, sexually transmitted diseases, GE, female sterility, liver and kidney disorders, as well as dropsy [8]. Phytochemical, antimicrobial, toxicity and antioxidant works have been previously reported of this plant [9, 10]. In the same logic, we have analysed the stem bark of Pteleopsis hylodendron and report here the antibacterial activity on pathogenic bacteria of the gastro-intestinal tract and antioxidant activity of the crude extract and fractions.

2. Material and Methods

2.1. Plant Material

The stem bark of P. hylodendron was collected in February 2009 at Mbeyengue I, Centre region of Cameroon. Identification was done at the National Herbarium in Yaoundé, Cameroon, where a voucher specimen (No 1309/SFRK) has been deposited.

2.2. Microorganisms

Five bacterial strains and six isolates known to be pathogenic of the gastro-intestinal tract were used in this work. These included three Gram+ bacteria (Enterococcus faecalis ATCC 10541, Staphylococcus aureus ATCC 25922 and Staphylococcus aureus) and eight Gram bacteria (Escherichia coli ATCC 11775, Escherichia coli, Proteus mirabilis, Pseudomonas aeruginosa ATCC 27853, Salmonella paratyphi A, Salmonella paratyphi B, Salmonella typhi ATCC 6539, and Shigella flexeneri). The bacterial isolates were obtained from Centre Pasteur of Yaoundé, Cameroon, while the reference strains were obtained from American Type Culture Collection (ATCC). The bacterial strains and isolates were grown at 35°C and maintained on nutrient agar. The bacterial cell suspension was prepared at 1.5 × 108 colony forming units per mL (CFU/mL) following the McFarland 0.5 turbidity standard.

2.3. Extraction and Fractionation

The air-dried and powdered stem bark of Pteleopsis hylodendron (2.5 kg) was extracted with MeOH (8 L, 72 h) at room temperature to obtain a crude extract (590 g) after evaporation under vacuum. A portion of this extract (100 g) was subjected to silica gel column chromatography (Ø8 cm × L30 cm) eluted successively with pure hexane, hexane-EtOAc (90 : 10–30 : 70), pure EtOAc, EtOAc-MeOH (95 : 5–80 : 20) and pure MeOH. Forty-six fractions of 500 mL each were collected and combined based on their TLC profile into ten major fractions A–J (A: 2-3, B: 4–6, C: 7–13, D: 14–16, E: 17–21, F: 22–28, G: 29–35, H: 36-37, I: 38–44, J: 45–46).

2.4. Antibacterial Assays

2.4.1. Agar-Well Diffusion Method

Diameters of inhibition zones (ID) were determined using Mueller Hinton Agar (MHA) by the well diffusion method [11]. The bacterial suspension (100 μL) was homogeneously seeded onto Petri dishes containing sterile molten MHA (20 mL). The sterile 6 mm diameter wells were impregnated (50 μL) with different concentrations of plant extract (10, 5, and 2.5 mg–200, 100, and 50 μg/mL). The dishes were kept for 1 h at room temperature for the diffusion of the extract. Subsequently, dishes were incubated at 35°C for 24 h. Antibiotics (Amoxicillin, Ciprofloxacin and Gentamicin) were used as positive control (10 μg–200 μg/mL) and 10% aqueous DMSO was used as negative control. Results were evaluated by measuring the inhibition zones around each well. The assay was done in triplicate and the mean diameters recorded as inhibition zones. We considered that an extract is active when ID was up to 20 mm, and then the strain is known as sensitive; moderately active when ID was between 10 and 20 mm, and then the strain is known as moderate; little or not active when ID was between 0 and 10 mm, and then the strain is known as little sensitive or resistant [12, 13].

2.4.2. Broth Microdilution Method

Minimum inhibitory concentrations (MICs) were determined using Mueller Hinton Broth (MHB) by microdilution method [14]. A two-fold serial dilution of the crude extract (12.50–0.024 mg/mL) and fractions (1000–1.953 μg/mL and 500–0.242 μg/mL). A negative control (10%, v/v aqueous DMSO, medium and inoculum) and positive control (10%, v/v aqueous DMSO, medium, inoculum and water-soluble antibiotics) were included. Each well of 96-well sterile microtitre plate received 100 μL of MHB, 100 μL of test substances and 100 μL of the bacterial inoculum (1.5 × 108 CFU/mL). The plates were covered and incubated at 35°C for 24 h. As an indicator of bacterial growth, 50 μL p-iodonitrotetrazolium violet (INT) dissolved in water was added to the wells and incubated at 35°C for 30 min. MIC values are recorded as the lowest concentration of the substance that completely inhibited bacterial growth that is, the solution in the well remained clear after incubation with INT. Minimum bactericidal concentrations (MBCs) were determined by plating 10 μL from each negative well and from the positive growth control on Mueller Hinton Agar. MBCs were defined as the lowest concentration yielding negative subcultures. The experiments were performed in triplicate. Amoxicillin, ciprofloxacin and gentamicin at the concentration ranging between 128 and 0.062 μg/mL served as positive control.

2.5. Antioxidant Assay

2.5.1. DPPH Assay

The free radical scavenging activity of the extract and fractions on the stable radical DPPH were estimated by the method of Mensor et al. [15]. 1.5 mL of a methanol solution of sample test at different concentrations (10, 50, 100, 500, and 1000 μg/mL) was mixed with a 0.3 mM DPPH methanol solution and kept for 30 min at room temperature. The decrease in the solution absorbance, due to proton donating of substances was measured at 517 nm. L-Ascorbic acid was used as positive control. The percentage of DPPH radical scavenging activity was calculated using the following formula:

DPPH  radical  scavenging  activity  (%)=  [(AcontrolAsampletest)Acontrol]  ×100.   (1)

2.5.2. β-Carotene-Linoleic Acid Assay

In this assay antioxidant capacity is determined by measuring the inhibition of the volatile organic compounds and the conjugated diene hydroperoxides arising from linoleic acid oxidation [16]. A stock solution of β-carotene-linoleic acid mixture was prepared as follows: 1.5 mg β-carotene was dissolved in 3 mL of chloroform, and 75 μL linoleic acid and 600 mg tween 40 were added. Chloroform was completely evaporated using a vacuum evaporator. Then 150 mL distilled water saturated with oxygen was added with a vigorous shaking. 1340 μL of this reaction mixture was dispersed to test tubes and 160 μL extract (20 mg/mL) were added, and emulsion system was incubated at 55°C for 105 min. Same procedure was repeated with L-Ascorbic acid used as a standard control and a blank. After this incubation period absorbance of the mixtures were measured at 492 nm. Antioxidative capacity of the extract was compared with those of ascorbic acid and blank.

2.6. Phytochemical Screening

Chemical tests were carried out on the methanolic extract and fractions using standard procedures to identify the constituents (alkaloids, anthocyanins, anthraquinones, coumarins, flavonoids, glycosides, phenols, polyphenols, saponins, tannins, triterpenes, and sterols) as described by Brunetton [17].

2.7. Statistical Analysis

Data were expressed as mean ± standard deviation. Statistical analysis was carried out using the Waller-Duncan's test. The 12.0 SPSS Windows software was used for this analysis. Differences were considered significant at P < .05.

3. Results

3.1. Extraction and Fractionation

The % yield of methanolic extract of P. hylodendron was 15.96%. FI (43.08%) and FJ (24.54%) were the most abundant.

3.2. Phytochemical Screening

Phytochemical screening revealed the presence of medicinally active constituents. The differences in the composition between crude extract and fractions and between fractions were noted. Except FA, all other substances contained at least one chemical group. Alkaloids, anthocyanins, anthraquinones, flavonoids, glycosides, phenols, polyphenols, saponins, and tannins were present in crude extract while coumarins, sterols, and triterpenes were absent. FB, FC, and FD had a similar chemical composition (alkaloids). It is the same for FG and FH (alkaloids, anthocyanins, anthraquinones, flavonoids, phenols, polyphenols, and tannins); FI and FJ (flavonoids, glycosides, phenols, polyphenols, saponins, and tannins).

3.3. Antibacterial Activity

The results of the antibacterial activity by the Agar-well diffusion method are presented in Table 1. At the three concentrations of the methanolic extract tested, ID ranged from 0.00 to 25.00 mm for all the bacteria 15.00–25.00 mm for the isolates 0.00–22.00 mm for the Gram, and 10.87–25.00 mm for the Gram+. S. aureus was the most sensitive (ID = 20.00–25.00 mm) while S. aureus ATCC 25922 and E. coli ATCC 11775 were the least sensitive (ID = 11.00–15.00 mm and 10.00–14.75 mm resp.). No activity was recorded at 2.5 mg against P. aeruginosa ATCC 27853. However these values are weak compared with those of the reference antibiotics (ID = 12–40 mm).

Table 1.

ID (mm) of the methanolic extract of P. hylodendron.

Bacteria Crude extract (mg/mL) Reference antibiotic (μg/mL)
P. hylodendron Amoxicillin Ciprofloxacin Gentamicin
200 100 50 200
Gram bacteria
E. coli ATCC 11775 14.75 ± 0.17f 12.25 ± 0.17h 10.00 ± 0.00g 19.00 ± 0.26d 28.25 ± 0.17f 27.00 ± 0.26f
E. coli 21.75 ± 0.13b 19.00 ± 0.00c 16.75 ± 0.17c 40.00 ± 0.00a 27.75 ± 0.17f 26.00 ± 0.00h
P. aeruginosa ATCC 27853 18.62 ± 0.27d 13.75 ± 0.17f 0.00 ± 0.00h 14.50 ± 0.42g 32.50 ± 0.17d 30.00 ± 0.00d
P. mirabilis 20.12 ± 0.12c 18.00 ± 0.00d 16.00 ± 0.00d 16.00 ± 0.00f 33.00 ± 0.00c 33.25 ± 0.17a
S. flexneri 21.75 ± 0.17b 19.75 ± 0.17b 17.50 ± 0.18b 20.00 ± 0.00c 36.50 ± 0.42a 32.00 ± 0.00b
S. paratyphi A 20.25 ± 0.17c 17.00 ± 0.00e 15.00 ± 0.00e 12.00 ± 0.00h 30.00 ± 0.00e 28.00 ± 0.00c
S. paratyphi B 19.75 ± 0.17c 17.62 ± 0.12d 15.12 ± 0.12e 14.25 ± 0.17g 35.00 ± 0.00b 28.25 ± 0.17e
S. typhi ATCC 6539 22.00 ± 0.00b 20.00 ± 0.00b 16.87 ± 0.12c 12.00 ± 0.00h 32.33 ± 0.25d 32.00 ± 0.00b
Gram+ bacteria
E. faecalis ATCC 10541 16.00 ± 0.00e 13.25 ± 0.17g 10.87 ± 0.12f 18.00 ± 0.00e 32.00 ± 0.00d 31.00 ± 0.00c
S. aureus ATCC 25922 15.00 ± 0.00f 13.75 ± 0.17f 11.00 ± 0.00f 20.75 ± 0.17c 35.50 ± 0.18c 30.25 ± 0.17cd
S. aureus 25.00 ± 0.00a 22.00 ± 0.00a 20.00 ± 0.00a 35.00 ± 0.00b 26.00 ± 0.00h 26.75 ± 0.24fh

a,b,c,d,e,f,g,hIn the same column, values carrying different letters in superscript are significantly different at P ≤ .05 (Waller Duncan test).

Diameters of inhibition zones (ID).

In view of the results obtained by diffusion method, MIC and MBC values of the crude extract and fractions were established and the results are shown in Tables 2 and 3.

Table 2.

MIC and MBC (μg/mL) of the methanolic extract of P. hylodendron.

Crude extract Reference antibiotics
Bacteria P. hylodendron Amoxicillin Ciprofloxacin Gentamicin
MIC MBC MBC/MIC MIC MBC MBC/MIC MIC MBC MBC/MIC MIC MBC MBC/MIC
Gram bacteria
E. coli ATCC 11775 3125 12500 4 128 4 4 1 16 128 8
E. coli 1562 1 1 1 8 8 1 1 1 1
P. aeruginosa ATCC 27853 781 781 1 128 1 16 16 8 16 2
P. mirabilis 781 6250 8 1 8 8 1 1 1 2 16 8
S. flexneri 3125 32 64 2 0.25 1 4 0.25 0.25 1
S. paratyphi A 12500 0.125 0.5 4 2 2 1
S. paratyphi B 1562 6250 4 1 8 8 0.5 2 4 2 16 8
S. typhi ATCC 6539 1562 6250 4 0.25 2 8 32 128 4
Gram+ bacteria
E. faecalis ATCC 10541 1562 6250 4 1 1 1 4 16 4 1 1 1
S. aureus ATCC 25922 3125 6250 2 8 8 1 4 16 4
S. aureus 781 1562 2 1 8 8 1 0.25 0.25 1

—:12500 μg/mL for the extract and >128 μg/mL for the reference antibiotics.

Table 3.

MIC and MBC (μg/mL) of the fractions from chromatography separation of P. hylodendron.

Bacteria Parameters Fractions Reference antibiotics
FA FB FC FD FE FF FG FH FI FJ Amox Cipro Genta
Gram bacteria
E. coli ATCC 11775 MIC 500 62.5 500 1000 1000 128 4 16
MBC 4 128
MBC/MIC 1 8
E. coli MIC 0.97 0.97 62.5 500 1000 1000 1 8 1
MBC 250 1 8 1
MBC/MIC 4 1 8 1
P. aeruginosa ATCC 27853 MIC 0.24 1000 1000 1000 128 1 8
MBC 250 16 16
MBC/MIC 20 16 2
P. mirabilis MIC 0.97 0.97 250 500 1000 1 1 2
MBC 125 62.5 8 1 16
MBC/MIC 14 12 8 1 8
S. flexneri MIC 250 500 1000 32 0.25 0.25
MBC 64 1 0.25
MBC/MIC 2 4 1
S. paratyphi A MIC 500 1000 1000 0.125 2
MBC 0.5 2
MBC/MIC 4 1
S. paratyphi B MIC 0.97 0.97 500 500 500 1000 1 0.5 2
MBC 8 2 16
MBC/MIC 8 4 8
S. typhi ATCC 6539 MIC 500 1000 0.25 32
MBC 2 128
MBC/MIC 8 4
Gram+ bacteria
E. faecalis ATCC 10541 MIC 0.97 0.97 0.24 500 1000 1000 1 4 1
MBC 0.97 250 0.24 1 16 1
MBC/MIC 1 16 1 1 4 1
S. aureus ATCC 25922 MIC 500 8 4
MBC 8 16
MBC/MIC 1 4
S. aureus MIC 0.97 0.97 0.24 500 125 250 1 8 0.25
MBC 0.97 8 0.25
MBC/MIC 4 1 1

F: fraction; Amox: amoxicillin; Cipro: ciprofloxacin; Genta: gentamicin.

—:>1000 μg/mL for the fractions, and >128 μg/mL for the reference antibiotic.

All the bacteria tested were inhibited by the methanolic extract (Table 2) with MIC ranging from 781–12500 μg/mL for all the bacteria, isolates, and Gram; 781–3125 μg/mL for the strains and Gram+. S. paratyphi A was the least sensitive (MIC = 12500 μg/mL). P. aeruginosa ATCC 27853, P. mirabilis and S. aureus were the most sensitive (MIC = 781 μg/mL). The important activity on S. aureus confirms the best activity obtained in solid medium; which revealed this germ as one of the most susceptible. Antibiotics exerted a higher inhibitory effect on bacterial (MIC = 0.125–128 μg/mL) than the methanolic extract.

The fractionation of the methanolic extract showed an inactivity of FA, FB, FC and FD on all the bacteria tested (Table 3). On the contrary, FE and FF saw their activity increasing significantly. Indeed, on five of the eleven bacteria (E. coli, P. mirabilis, S. paratyphi B, E. faecalis ATCC 10541, S. aureus), MIC was 0.97 μg/mL, making the substances more active than reference antibiotics. FG had a fairly good activity (MIC = 0.24 μg/mL) on some bacteria (P. aeruginosa ATCC 27853, E. faecalis ATCC 10541, S. aureus) whereas FH, FI and FJ were slightly active (MIC = 125–1000 μg/mL). S. aureus ATCC 25922 was almost resistant to all the fractions (MIC > 1000 μg/mL). The MBC/MIC ratio activity for all the bacteria tested varied between one (1) and eight (8) for the crude extract and between one (1) and twenty (20) for the fractions. According to Marmonier [18], plant extract and fractions exerted two types of activities: a bacteriostatic (MBC/MIC ≥ 4) and bactericidal activity (MBC/MIC ≤ 4). Methanolic extract and fractions of P. hylodendron were bactericidal on at least 63% and 27% of the bacteria respectively.

3.4. Antioxidant Activity

The antioxidant activity of the methanolic extract and fractions was assessed by the DPPH and β-carotene-linoleic acid assays. The results are presented in Tables 4 and 5. Activity increased in a concentration-dependant manner compared to L-ascorbic acid (positive antioxidant control). At the concentrations of 500 and 1000 μg/mL the methanolic extract, FE, FF, FG, FH, FI and FJ showed a similar activity to that one of L-ascorbic acid. FH  was the most antioxidant fraction (94.05–98.79%) while FA  was the least antioxidant (1.86–21.26%).

Table 4.

Antioxidant potential of the crude extract and fractions of P. hylodendron and L- ascorbic acid in DPPH assay.

Substances tested % inhibition concentration (μg/mL)
1000 500 100 50 10
FA 21.26 ± 0.24f 19.69 ± 0.17i 11.83 ± 0.47ef 05.28 ± 0.26j 1.86 ± 0.17m
FB 22.40 ± 0.94f 18.80 ± 0.10j 09.19 ± 0.20f 08.83 ± 0.34i 04.20 ± 0.17l
FC 42.58 ± 0.50e 28.16 ± 0.29h 12.31 ± 0.41e 10.87 ± 0.38h 08.65 ± 0.00k
FD 67.98 ± 0.72d 52.13 ± 0.10g 20.24 ± 0.45d 17.83 ± 0.28g 10.81 ± 0.37j
FE 95.73 ± 0.26bc 94.95 ± 0.00d 94.05 ± 0.14a 91.77 ± 0.33cd 26.30 ± 0.20h
FF 95.37 ± 0.10bc 94.65 ± 0.10d 93.75 ± 0.10a 93.33 ± 0.14ab 83.42 ± 0.48d
FG 97.83 ± 0.37ab 95.55 ± 0.17c 94.65 ± 0.17a 92.79 ± 0.29bc 91.89 ± 0.28b
FH 98.79 ± 0.33ab 96.21 ± 0.13b 94.47 ± 0.26a 94.29 ± 0.26a 94.05 ± 0.20a
FI 95.49 ± 0.14bc 94.83 ± 0.17d 93.93 ± 0.33a 92.67 ± 0.38bc 70.08 ± 0.64f
FJ 95.85 ± 0.00bc 95.13 ± 0.14cd 93.57 ± 0.30a 93.21 ± 0.17ab 74.23 ± 0.14e
PH 95.13 ± 0.14bc 93.87 ± 0.28e 93.39 ± 0.10a 91.35 ± 0.14d 89.42 ± 0.26c
ASC 100.00 ± 0.00a 100.00 ± 0.00a 87.36 ± 0.00b 53.23 ± 0.00e 29.42 ± 0.00g

F: fraction; PH: methanolic extract of P. hylodendron; ASC: L-ascorbic acid.

a,b,c,d,e,f,g,h,i,j,k,l,mIn the same column, values carrying different letters in superscript are significantly different at P ≤ .05 (Waller Duncan test).

Table 5.

Antioxidant potential of the crude extract of P. hylodendron and L-ascorbic acid in β-carotene-linoleic acid assay.

Substances tested % inhibition concentration (μg/mL)
1000 500 100 50 10
PH 38.03 ± 0.25b 31.83 ± 0.16a 31.80 ± 0.00a 30.47 ± 0.08a 27.73 ± 0.08a
ASC 56.48 ± 0.05a 27.73 ± 0.02b 20.20 ± 0.00b 19.86 ± 0.00b 17.81 ± 0.02b

PH: methanolic extract of P. hylodendron; ASC: L-ascorbic acid.

a,bIn the same column, values carrying different letters in superscript are significantly different at P ≤ .05 (Waller Duncan test).

4. Discussion and Conclusion

Phytochemical screening of the methanolic extract and fractions of P. hylodendron revealed the presence alkaloids, anthocyanins, anthraquinones, flavonoids, glycosides, phenols, polyphenols, saponins and tannins. Other investigators [19, 20] have reported the presence of these components in the Combretaceae family to which belongs the studied plant. However, Ngounou et al. [21] and Atta-Ur-Rahman et al. [22] working on the stem bark of P. hylodendron collected from East region of Cameroon revealed the presence of triterpenes which were absent in our sample. This difference can be attributed to the difference in the geographical region, soil composition, and age of the plant [17].

The antimicrobial activities of Pteleopsis species were reported [19, 23]. Generally, the methanolic extract and some fractions of the stem bark of P. hylodendron showed variable antibacterial activities dose-dependant on the eleven bacterial strains and isolates tested. These broad spectra of action could be related to their chemical components [24]. Among these compounds, tannins induce an important antimicrobial activity because they have an ability to inactivate microbial adhesions, enzymes, cell envelope transport proteins, and so forth, [25]. Due to their ability to bind to proteins and metals, tannins also inhibit the growth of microorganisms through substrate and metal ion deprivation [26]. However, differences in chemical composition recorded between the crude extract and some fractions may explain their different degree of antimicrobial properties. Also, the amount of the active components in the crude extract may be diluted and fractionation may have increased their concentrations, thus the activities in the fractions [27]. Moreover, the differences in susceptibility may be explained by the differences in cell wall composition and/or genetic content of plasmids that can be easily transferred among strains [28]. MIC values obtained from the extract by micro-dilution method revealed that S. aureus is the most sensitive. It was reported [29] that S. aureus is one of the most susceptible bacteria to the plant extracts. These values also showed that the Gram and Gram+ bacteria had a comparable susceptibility. This may suggest that the mode of action of the extract was not related to the cell wall composition. S. aureus ATCC 25922 which was inhibited completely by the methanolic extract at 3125 μg/mL, was almost resistant to all the fractions. This may suggest that this microbe required high concentrations of the substance tested and synergic effect of chemical compounds as extract. FA, FB, FC, and FD containing only alkaloids did not show any inhibitory effect on the bacteria tested. This may suggest these compounds which also present in the methanolic extract do not have a detectable antibacterial activity. However, alkaloids were reported to possess antibacterial activities [30]. FE and FF, most active had a comparable chemical composition that FG. Differences in activity between these fractions could be related to the absence of anthocyanins in FF and anthraquinones in FE. Generally, it is difficult at the sight of results of the phytochemical screening to attribute the activities recorded to a chemical compounds group.

As L-ascorbic acid, the methanolic extract and some fractions showed great antioxidant potentials. This particularly high activity could be attributed to the presence of phenolic compounds [31]. The antioxidant activity of phenolic compounds is mainly due to their redox properties, which can play an important role in neutralizing free radicals, quenching singlet and triplet oxygen species, or decomposing peroxides [32]. Numerous studies have suggested flavonoids, anthraquinones, anthocyanins and tannins [33, 34] for antioxidant activity. Previous phytochemical investigations on this plant have reported the presence of ellagic acid derivatives as antioxidant source [22].

These results provide promising baseline information for the potential use of this plant as well as some of the fractions in the treatment of GE and oxidative stress. FE and FF by their high antibacterial activity could be the base of development of new antibacterial agents with broad spectra. Their purification and pharmacological and toxicity studies are essential.

Acknowledgment

This work was supported by AIRES-Sud, a programme from the French Ministry of Foreign and European Affairs implemented by the “Institut de Recherche pour le Développement (IRD-DSF)”.

References

  • 1.Kouznetsov JM, Lopez SN, Vargas M, et al. In vitro antifungal activity of news series of homoallylamines and related compound with inhibitory properties of the synthesis of fungal cell wall polymers. Bioorganic and Medical Chemistry. 2003;11:1532–1550. doi: 10.1016/s0968-0896(02)00605-3. [DOI] [PubMed] [Google Scholar]
  • 2.Louis JP, Trebucq A, Badjamo MG, et al. Les maladies diarrhéiques infantiles en République Centrafricaine : enquête épidémiologique dans la région sanitaire N°3. Médécine d’Afrique Noire. 1991;38(4):281–283. [Google Scholar]
  • 3.World Health Organization. Guidelines for control of epidemics due to shigella dysenteriae. WHO. 2007;8:p. 4. [Google Scholar]
  • 4.Matu EN, Van Staden J. Antibacterial and anti-inflammatory activities of some plants used for medicinal purposes in Kenya. Journal of Ethnopharmacology. 2003;87(1):35–41. doi: 10.1016/s0378-8741(03)00107-7. [DOI] [PubMed] [Google Scholar]
  • 5.Press JB. Biodiversity: exciting prospects for drug discovery and development”, Meeting report of the Monroe wall symposium. Chemical Abstracts-Organic Chemistry. 1996;9:286–298. [Google Scholar]
  • 6.Megne BC. Contribution à l’étude des plantes médicinales du Cameroun: inventaire de quelques plantes utilisées dans le traitement des MST dans la region de Dschang (Ouest Cameroun) Mémoire de Maîtrise de biologie et physiologie végétale, Université de Dschang, pp. 51, 1998.
  • 7.Liben L. “Flore du Cameroun: combretaceae”, Délégation générale à la recherche scientifique et technique. Yaoundé. 1983;25:p. 12. [Google Scholar]
  • 8.Motso CPR. Recensement de quelques plantes Camerounaises à activité antivirale. Mémoire de Maîtrise de Biochimie, Université de Douala, pp. 25-27, 2007.
  • 9.Atta-Ur-Rahman, Ngounou FN, Choudhary MI, et al. New antioxidant and antimicrobial ellagic acid derivatives from Pteleopsis hylodendron . Planta Medica. 2001;67(4):335–339. doi: 10.1055/s-2001-14306. [DOI] [PubMed] [Google Scholar]
  • 10.Magnifouet NH. Etude de la toxicité de l’extrait aqueux et méthanolique de Pteleopsis hylodendron (Combretaceae) Université de Dschang; 2009. Thèse de Master de Biochimie. [Google Scholar]
  • 11.Berghe VA, Vlietinck AJ. Screening methods for antibacterial and antiviral agents from higher plants. Methods for Plant Biochemistry. 1991;6:47–68. [Google Scholar]
  • 12.Leclerc H. Microbiologie Générale. Paris, France: Doin; 1975. [Google Scholar]
  • 13.Duarte MCT, Figueira GM, Sartoratto A, Rehder VLG, Delarmelina C. Anti-Candida activity of Brazilian medicinal plants. Journal of Ethnopharmacology. 2005;97(2):305–311. doi: 10.1016/j.jep.2004.11.016. [DOI] [PubMed] [Google Scholar]
  • 14.Newton SM, Lau C, Gurcha SS, Besra GS, Wright CW. The evaluation of forty-three plant species for in vitro antimycobacterial activities; isolation of active constituents from Psoralea corylifolia and Sanguinaria canadensis. Journal of Ethnopharmacology. 2002;79(1):57–67. doi: 10.1016/s0378-8741(01)00350-6. [DOI] [PubMed] [Google Scholar]
  • 15.Mensor L-L, Menezes FS, Leitao GG, et al. Screening of Brazilian plant extracts for antioxidant activity by the use of DPPH free radical method. Phytotherapy Research. 2001;15(2):127–130. doi: 10.1002/ptr.687. [DOI] [PubMed] [Google Scholar]
  • 16.Koleva II, Van Beek TA, Linssen JPH, De Groot A, Evstatieva LN. Screening of plant extracts for antioxidant activity: a comparative study on three testing methods. Phytochemical Analysis. 2002;13(1):8–17. doi: 10.1002/pca.611. [DOI] [PubMed] [Google Scholar]
  • 17.Brunetton J. Pharmacognosie, Phytochimie-Plantes Médicinales-Techniques et Documentations. 3rd edition. Paris, France: Lavoisier; 1999. [Google Scholar]
  • 18.Marmonier AA. Bactériologie Médicale, Techniques Usuelles. Paris, France: Doin; 1990. Introduction aux techniques d’étude des antibiotiques; pp. 227–236. [Google Scholar]
  • 19.Baba-Moussa F, Akpagana K, Bouchet P. Antifungal activities of seven West African Combretaceae used in traditional medicine. Journal of Ethnopharmacology. 1999;66(3):335–338. doi: 10.1016/s0378-8741(98)00184-6. [DOI] [PubMed] [Google Scholar]
  • 20.Silva O, Ferreira E, Vaz Pato M, Caniça M, Gomes ET. In vitro anti-Neisseria gonorrhoeae activity of Terminalia macroptera leaves. FEMS Microbiology Letters. 2002;217(2):271–274. doi: 10.1111/j.1574-6968.2002.tb11487.x. [DOI] [PubMed] [Google Scholar]
  • 21.Ngounou FN, Atta-Ur-Rahman, Choudhary MI, et al. Two saponins from Pteleopsis hylodendron . Phytochemistry. 1999;52(5):917–921. doi: 10.1016/j.phytochem.2008.05.006. [DOI] [PubMed] [Google Scholar]
  • 22.Atta-ur-Rahman, Zareen S, Choudhary MI, Akhtar MN, Ngounou FN. A triterpenoidal saponin and sphingolipids from Pteleopsis hylodendron . Phytochemistry. 2008;69(12):2400–2405. doi: 10.1016/j.phytochem.2008.05.006. [DOI] [PubMed] [Google Scholar]
  • 23.Germanò MP, Sanogo R, Guglielmo M, De Pasquale R, Crisafi G, Bisignano G. Effects of Pteleopsis suberosa extracts on experimental gastric ulcers and Helicobacter pylori growth. Journal of Ethnopharmacology. 1998;59(3):167–172. doi: 10.1016/s0378-8741(97)00109-8. [DOI] [PubMed] [Google Scholar]
  • 24.Wabo HK, Kouam SF, Krohn K, et al. Prenylated anthraquinones and other constituents from the seeds of Vismia laurentii . Chemical and Pharmaceutical Bulletin. 2007;55(11):1640–1642. doi: 10.1248/cpb.55.1640. [DOI] [PubMed] [Google Scholar]
  • 25.Cowan MM. Plant products as antimicrobial agents. Clinical Microbiology Reviews. 1999;12(4):564–582. doi: 10.1128/cmr.12.4.564. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Scalbert A. Antimicrobial properties of tannins. Phytochemistry. 1991;30(12):3875–3883. [Google Scholar]
  • 27.Tamokou JD, Kuiate JR, Njateng GSS, et al. Antimicrobial activity of dichloromethane-methanol (1:1 v/v) extract from the stem bark of Couta edutis Bail. (Olacaceae) Research Journal of Microbiology. 2008;3(6):414–422. [Google Scholar]
  • 28.Karaman I, Şahin F, Güllüce M, Öğütçü H, Şengül M, Adigüzel A. Antimicrobial activity of aqueous and methanol extracts of Juniperus oxycedrus L. Journal of Ethnopharmacology. 2003;85(2-3):231–235. doi: 10.1016/s0378-8741(03)00006-0. [DOI] [PubMed] [Google Scholar]
  • 29.Chariandy CM, Seaforth CE, Phelps RH, Pollard GV, Khambay BPS. Screening of medicinal plants from Trinidad and Tobago for antimicrobial and insecticidal properties. Journal of Ethnopharmacology. 1999;64(3):265–270. doi: 10.1016/s0378-8741(98)00130-5. [DOI] [PubMed] [Google Scholar]
  • 30.Jouzier E. Solanacées médicales et Philatélie. Bulletin de Société de Pharmacie. 2005;144:313–332. [Google Scholar]
  • 31.Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. Journal of the American Medical Association. 2007;297(8):842–857. doi: 10.1001/jama.297.8.842. [DOI] [PubMed] [Google Scholar]
  • 32.Rice-Evans CA, Miller NJ, Paganga G. Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radical Biology and Medicine. 1996;20(7):933–956. doi: 10.1016/0891-5849(95)02227-9. [DOI] [PubMed] [Google Scholar]
  • 33.Smith AH, Imlay JA, Mackie RI. Increasing the oxidative stress response allows Escherichia coli to overcome inhibitory effects of condensed tannins. Applied and Environmental Microbiology. 2003;69(6):3406–3411. doi: 10.1128/AEM.69.6.3406-3411.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Nićiforović A, Adžić M, Spasić SD, Radojčić MB. Antitumor effects of a natural anthracycline analog (aloin) involve altered activity of antioxidant enzymes in HeLaS3 cells. Cancer Biology and Therapy. 2007;6(8):1200–1205. doi: 10.4161/cbt.6.8.4383. [DOI] [PubMed] [Google Scholar]

Articles from Chemotherapy Research and Practice are provided here courtesy of Wiley

RESOURCES